Tristan Juhan, MD
Sports Medicine · Mountain View, CANPI 1720441298
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $24,890 with a category attached, or 80.4%. Arthrex accounts for 94.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $20,000 and has fallen 99.4% since, to $119 in 2025.
Across 31 payments — averaging $802.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$23K
- Zimmer Biomet$893
- Stryker$307
- Evolution Surgical, Inc$232
- Electronic Waveform Lab, Inc.$36
- Amgen$29
What the payments were for
- Grants$20,00080%
- Travel & lodging$7363%
- Food & beverage$8613%
- Education$3,29313%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $23,393 |
| Zimmer Biomet | 1 | $893 |
| Stryker | 5 | $307 |
| Evolution Surgical, Inc | 3 | $232 |
| Electronic Waveform Lab, Inc. | 1 | $36 |
| Amgen | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COMPREHENSIVE$893
- AEQUALIS PERFORM$110
How this compares
$24,890 in reported general payments places this provider in the 80th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 11 | $78 |
| Meloxicam | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Mountain View
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Michael FreehillStanford$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Seth ShermanStanford$1.1M
- Stephan YacoubianBurbank$1M
- Stephen Snydervan Nuys$922K
- Deryk JonesSan Carlos$915K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.